156 related articles for article (PubMed ID: 17869010)
1. Endothelial progenitor cells as cellular vehicles to deliver oncolytic virus therapies to metastatic tumors: the "Trojan horse" approach.
Deng W; Jia J
Med Hypotheses; 2008; 70(4):842-4. PubMed ID: 17869010
[TBL] [Abstract][Full Text] [Related]
2. Striking out at disseminated metastases: the systemic delivery of oncolytic viruses.
Fisher K
Curr Opin Mol Ther; 2006 Aug; 8(4):301-13. PubMed ID: 16955693
[TBL] [Abstract][Full Text] [Related]
3. Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.
Munguia A; Ota T; Miest T; Russell SJ
Gene Ther; 2008 May; 15(10):797-806. PubMed ID: 18356812
[TBL] [Abstract][Full Text] [Related]
4. Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy.
Power AT; Bell JC
Gene Ther; 2008 May; 15(10):772-9. PubMed ID: 18369325
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.
García-Castro J; Martínez-Palacio J; Lillo R; García-Sánchez F; Alemany R; Madero L; Bueren JA; Ramírez M
Cancer Gene Ther; 2005 Apr; 12(4):341-9. PubMed ID: 15650763
[TBL] [Abstract][Full Text] [Related]
6. Potential of tumour cells for delivering oncolytic viruses.
Raykov Z; Rommelaere J
Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.
García-Castro J; Alemany R; Cascalló M; Martínez-Quintanilla J; Arriero Mdel M; Lassaletta A; Madero L; Ramírez M
Cancer Gene Ther; 2010 Jul; 17(7):476-83. PubMed ID: 20168350
[TBL] [Abstract][Full Text] [Related]
8. Viruses, gene therapy and stem cells for the treatment of human glioma.
Kyritsis AP; Sioka C; Rao JS
Cancer Gene Ther; 2009 Oct; 16(10):741-52. PubMed ID: 19644531
[TBL] [Abstract][Full Text] [Related]
9. The utility of cells as vehicles for oncolytic virus therapies.
Russell SJ; Peng KW
Curr Opin Mol Ther; 2008 Aug; 10(4):380-6. PubMed ID: 18683103
[TBL] [Abstract][Full Text] [Related]
10. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
Thorne SH; Contag CH
Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
12. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
[TBL] [Abstract][Full Text] [Related]
13. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
Wei J; Wahl J; Nakamura T; Stiller D; Mertens T; Debatin KM; Beltinger C
Gene Ther; 2007 Nov; 14(22):1573-86. PubMed ID: 17898797
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for glioblastoma.
Aghi M; Chiocca EA
Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
[TBL] [Abstract][Full Text] [Related]
15. Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.
Ahmed AU; Ulasov IV; Mercer RW; Lesniak MS
Methods Mol Biol; 2012; 797():97-109. PubMed ID: 21948472
[TBL] [Abstract][Full Text] [Related]
16. Viral gene therapy strategies: from basic science to clinical application.
Young LS; Searle PF; Onion D; Mautner V
J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
[TBL] [Abstract][Full Text] [Related]
17. [Oncolytic virus therapy for malignant brain tumors].
Ino Y; Todo T
Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
Varghese S; Rabkin SD; Nielsen GP; MacGarvey U; Liu R; Martuza RL
Cancer Res; 2007 Oct; 67(19):9371-9. PubMed ID: 17909046
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
Ganesh S; Gonzalez-Edick M; Gibbons D; Van Roey M; Jooss K
Clin Cancer Res; 2008 Jun; 14(12):3933-41. PubMed ID: 18559615
[TBL] [Abstract][Full Text] [Related]
20. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
